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Abstract
Objective—Our previous study suggested that growth arrest and DNA damage–inducible protein
45β (GADD45β) prolonged the survival of hypertrophic chondrocytes in the developing mouse
embryo. This study was undertaken, therefore, to investigate whether GADD45β plays a role in
adult articular cartilage.
Methods—Gene expression profiles of cartilage from patients with late-stage osteoarthritis (OA)
were compared with those from patients with early OA and normal controls in 2 separate
microarray analyses. Histologic features of cartilage were graded using the Mankin scale, and
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GADD45β was localized by immunohistochemistry. Human chondrocytes were transduced with
small interfering RNA (siRNA)–GADD45β or GADD45β-FLAG. GADD45β and COL2A1
messenger RNA (mRNA) levels were analyzed by real-time reverse transcriptase–polymerase
chain reaction, and promoter activities were analyzed by transient transfection. Cell death was
detected by Hoechst 33342 staining of condensed chromatin.
Results—GADD45β was expressed at higher levels in cartilage from normal donors and patients
with early OA than in cartilage from patients with late-stage OA. All chondrocyte nuclei in normal
cartilage immunostained for GADD45β. In early OA cartilage, GADD45β was distributed variably
in chondrocyte clusters, in middle and deep zone cells, and in osteophytes. In contrast, COL2A1,
other collagen genes, and factors associated with skeletal development were up-regulated in late
OA, compared with early OA or normal cartilage. In overexpression and knockdown experiments,
GADD45β down-regulated COL2A1 mRNA and promoter activity. NF-κB overexpression
increased GADD45β promoter activity, and siRNA-GADD45β decreased cell survival per se and
enhanced tumor necrosis factor α–induced cell death in human articular chondrocytes.
Conclusion—These observations suggest that GADD45β might play an important role in
regulating chondrocyte homeostasis by modulating collagen gene expression and promoting cell
survival in normal adult cartilage and in early OA.
Osteoarthritis (OA) is defined largely as a disease of cartilage, since chondrocytes, which
constitute the unique cellular component of adult articular cartilage, are able to respond to
mechanical injury, joint instability due to genetic factors, and biologic stimuli such as
cytokines and growth and differentiation factors. In young individuals without genetic
abnormalities, biomechanical factors due to trauma are strongly implicated in initiating the
OA lesion (1,2). Mechanical disruption of cell–matrix interactions may lead to aberrant
chondrocyte behavior that is reflected in the appearance of fibrillations, cell clusters, and
changes in quantity, distribution, or composition of matrix proteins (3). In the early stages of
OA, a transient increase in chondrocyte proliferation is associated with increased synthesis
of catabolic cytokines and matrix-degrading enzymes. Local loss of proteoglycans and
cleavage of type II collagen occur initially at the cartilage surface, resulting in an increase in
water content and a loss of tensile strength in the cartilage matrix as the lesion progresses.
A number of studies have demonstrated enhanced biosynthesis and increased global gene
expression of aggrecan and type II collagen in human OA cartilage (4,5). The increased
levels of anabolic factors such as bone morphogenetic protein 2 (BMP-2) and inhibin βA/
activin suggest a possible mechanism of cartilage anabolism (5–7). Nevertheless, Aigner and
coworkers have shown that expression of the type II collagen gene (COL2A1) is suppressed
in upper zones with progressing matrix destruction, whereas global COL2A1 gene
expression is increased in late-stage OA cartilage compared with normal and early
degenerative cartilage (8–10). Phenotypic modulation, with expression of collagens
normally absent in adult articular cartilage or at atypical sites in OA cartilage, has been
proposed (11). Once the cartilage is severely degraded, the chondrocyte is unable to
replicate the complex arrangement of collagen laid down during development. Furthermore,
the chondrocyte stress response may result in the loss of viable cells due to apoptosis or
senescence (12).
Growth arrest and DNA damage–inducible protein 45β (GADD45β) is a member of a family
of small (18-kd) proteins that respond to genotoxic stress. Initially, GADD45β, encoded by
myeloid differentiation factor 118, was identified as a primary response gene activated in
murine myeloid leukemia cells by interleukin-6 during terminal differentiation (13,14).
Microarray studies have shown that another family member, GADD45α, is expressed at
higher levels in normal cartilage than in OA (9) and is induced by hydrostatic pressure (15).
Recently, we identified GADD45β as a BMP-2–induced early gene in chondrocytes and as
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an essential mediator of Col10a1 and Mmp13 gene expression in late-stage hypertrophic
chondrocytes in the mouse embryo (16). Since the hypertrophic zone was compressed in
Gadd45b-deficient embryonic growth plates, we hypothesized that GADD45β may act as a
cell survival factor during terminal differentiation (16).
In 2 separate global analyses of gene expression in cartilage, we showed in this study that
chondrocytes express GADD45β messenger RNA (mRNA) at higher levels in cartilage from
normal donors and patients with early OA than in cartilage from patients with late-stage OA.
However, the distribution of GADD45β in chondrocyte clusters and in osteophytes in OA
cartilage suggests different roles of GADD45β in OA compared with normal cartilage,
where GADD45β is localized in the nuclei of all chondrocytes. Interestingly, overexpression
of GADD45β down-regulates COL2A1 promoter activity in chondrocytes, consistent with
the reciprocal expression of the 2 genes in cartilage from patients with early and late OA.
GADD45β gene transcription is induced by NF-κB, and endogenous levels of GADD45β
promote cell survival and protect against tumor necrosis factor α (TNFα)–induced cell death
in chondrocytes. These results may explain how cartilage damage and other environmental
stresses influence the survival and anabolic activities of chondrocytes in OA cartilage.
MATERIALS AND METHODS
Cartilage samples
Human articular cartilage samples were obtained from discarded surgical material or from
cadavers, with the approval of the Institutional Review Boards of the Beth Israel Deaconess
Medical Center (BIDMC), New England Baptist Hospital, the University of Erlangen–
Nuremberg (Erlangen, Germany), the Graduate School of Medicine and Dentistry,
Kagoshima University, and the Hospital for Special Surgery.
RNA isolation and microarray analysis
Cartilage samples were rapidly frozen in liquid nitrogen, and total RNA was isolated as
previously described (17,18). Transcription profiling of RNA samples derived from cartilage
from 3 patients with early OA (mean age 72 years) and 3 patients with late OA (mean age
78 years) was performed at the BIDMC Genomics Center, using the GeneChip Human
Genome U133A array (Affymetrix, Santa Clara, CA) containing 22,283 genes. Array
experiments were performed according to the recommendations of the manufacturer with 1
μg of total RNA per sample. After polymerase chain reaction (PCR) amplification of each
sample, complementary DNA fragments were hybridized with a pre-equilibrated Affymetrix
chip, washed, stained, and scanned in the HP ChipScanner (Affymetrix), as previously
described (19). Microarray analysis of RNA extracts from cartilage samples from 13 normal
individuals (mean age 71.7 years [range 48–87 years]) and 12 patients with late-stage OA
(mean age 64.7 years [range 60–84 years]) diagnosed according to the American College of
Rheumatology criteria (20), was performed at the Münster University Genomics Center
(Münster, Germany), using the Affymetrix GeneChip Human Genome U133 Plus 2.0 Array
for >47,000 transcripts.
Analysis with dChip software
Scanned array images were analyzed using dChip (21), which has been shown to be more
robust than Affymetrix Microarray Analysis Suite software, version 5.0, in signal
calculation for ~60% of genes (22). In the dChip analysis, a smoothing spline normalization
method was applied prior to obtaining model-based gene expression indices, also known as
signal values. Single, array, and probe outliers were interrogated as described in dChip,
where image spikes are treated as single outliers. Since no outlier chip was identified, all
samples were used for subsequent analysis. To compare cartilage samples from patients with
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early and late-stage OA, we used the lower confidence bound, which is a stringent estimate
of the fold change and has been shown to be the better ranking statistic (23). We used the
dChip method to assess differentially expressed genes according to the lower confidence
bound, since it is superior to other commonly used approaches, such as the Affymetrix
Microarray Analysis Suite 5.0 algorithm and Robust Multiarray Average (24,25). If the
lower confidence bound of the fold change between the experiment and the baseline was
>1.2, we considered the corresponding gene to be differentially expressed. Studies using
custom arrays and quantitative real-time reverse transcriptase (RT)–PCR have suggested
that Affymetrix chips may underestimate differences in gene expression (26). Based on this
work and others (27), a criterion of selecting genes that have a lower confidence bound >1.2
most likely corresponds to genes with an “actual” fold change of ≥3 in gene expression.
Real-time RT-PCR
Total RNA (1.0 μg) was reverse-transcribed in 20 μl containing final concentrations of 2.4
IU/μl of murine leukemia virus reverse transcriptase, 2.5 μM of oligo(dT)16, and 1 unit/μl of
RNase inhibitor, all obtained from Applied Biosystems (Foster City, CA). Amplifications
were carried out using SYBR Green I–based real-time PCR on the MJ Research DNA
Engine OpticonTM Continuous Fluorescence Detection System (MJ Research, Waltham,
MA), as previously described (16,28). For each run, serial dilutions of GAPDH plasmids
were used as standards for quantitative measurement of the amount of amplified DNA. All
samples were run in triplicate, and the data were calculated as the ratio of GADD45β or
COL2A1 to GAPDH. The primers used for real-time PCR were as follows: for GADD45β,
5′-TCGGATTTTGCAATTTCTCC-3′ (sense) and 5′-GGATGAGCGTGAAGTGGATT-3′
(antisense); for human GAPDH, 5′-CAAAGTTGTCATGGATGACC-3′ (sense) and 5′-
CCATGGAGAAGGCTGGGG-3′ (antisense); and for human COL2A1, 5′-
CAACACTGCCAACGTCCAGAT-3′ (sense) and 5′-
CTGCTTCGTCCAGATAGGCAAT-3′ (antisense).
Immunohistochemistry
Articular cartilage samples were obtained from hip joints from 4 asymptomatic donors
(mean age 81.5 years) undergoing joint replacement for femoral neck fracture and from knee
joints from 10 patients (mean age 74 years) undergoing total knee arthroplasty because of
symptomatic OA. Multiple areas of cartilage (0.5 × 0.5 cm2) were fixed in 4%
paraformaldehyde for 4 hours at room temperature and embedded in paraffin. Serial sections
of 8 μm were cut and stained with toluidine blue. Histologic features were assessed, and
sections were assigned a grade on the Mankin scale (29). Sections of fixed and paraffin-
embedded cartilage were deparaffinized and blocked with normal horse serum or protein
block (Dako x0909; Dako, Carpinteria, CA). Immunohistochemical analysis for GADD45β
was performed as previously described (16,30), using goat polyclonal anti-GADD45β
(sc-8776; Santa Cruz Biotechnology, Santa Cruz, CA) in a 1:400 dilution (0.5 μg/ml final
concentration), rabbit biotinylated anti-goat IgG (Sigma, St. Louis, MO), and the Vectastain
Elite ABC kit (Vector, Burlingame, CA.). Sections were counterstained with hematoxylin.
For negative controls, normal goat IgG (sc-2028) was used in place of the primary antibody
against GADD45β.
Cell culture
The immortalized human chondrocyte cell line, C-28/I2, was cultured in Dulbecco’s
modified Eagle’s medium (DMEM)–Ham’s F-12 (1/1 [volume/volume]) (Invitrogen, San
Diego, CA) containing 10% fetal calf serum (FCS) (Biowhittaker, Walkersville, MD), as
previously described (31,32). For experiments, subconfluent cultures were moved to
medium containing 1% Nutridoma-SP (Roche, Indianapolis, IN) or 1% serum for 18 hours
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for mild starvation. Primary chondrocytes were isolated by sequential digestion with
Pronase and collagenase P (Invitrogen) from human articular cartilage obtained from intact
regions of femoral condyles from patients undergoing total knee replacement surgery, and
cultured to confluence in DMEM–Ham’s F-12 containing 10% FCS.
Transient transfections using luciferase reporter constructs and expression plasmids
The human GADD45β promoter fragment spanning −1,604 to +141 bp was prepared by
PCR using human genomic DNA (BD Clontech, Basing-stoke, UK) as template, as
previously described (16). The −496 to +141 bp construct was prepared by PCR using the
PfuTurbo DNA polymerase (Stratagene, La Jolla, CA) and the −1,604 to +141 bp construct
as template. The COL2A1 sequence spanning −577 to +3,428 bp was cloned into the pGL2-
basic (pGL2-B) luciferase reporter gene vector (Promega, Madison, WI) to generate
pGL2B-COL2 (33). The pcDNA3-GADD45β-FLAG and pcDNA3-FLAG empty vector and
the NF-κB p65 and p50 expression vectors have been reported previously (16,34). The
transduction of C-28/I2 cells with lentiviral–small interfering RNA (siRNA)–green
fluorescent protein (GFP) (GFP–knockdown [KD]) or lentiviral-siRNA-GADD45β
(GADD45β-KD) and tests for specificity and efficiency of knockdown have been described
previously (16). Transient transfection experiments were carried out using C-28/I2 cells with
Plus and Lipofectamine reagents (Invitrogen), as previously described (16,32). Luciferase
activity was determined by the Dual Luciferase Assay using the Autolumat LB953
luminometer (EG&G Berthold, Oak Ridge, TN). Each experiment was repeated at least 3
times and each data point was calculated as the mean ± SD of 3–6 wells per experiment.
Hoechst staining
Primary human articular chondrocytes, obtained from 5 patients (2 men and 3 women) with
OA (age range 53–70 years) who underwent total knee replacement, were passaged at a
density of 2.5 × 104 cells/cm2 and transfected with 50 nM of siRNA oligos against GFP
(sense GCAAGCUGACCCUGAAGUUCAU and antisense
GAACUUCAGGGUCAGCUUGCCG) or against GADD45β (Hs_GADD45B_6_HP
siRNA; Qiagen, Chatsworth, CA) using Plus and Lipofectamine reagents. Transfection
efficiency was assessed using siRNA GFP conjugated with rhodamine. The GADD45β
siRNA sequences were selected from among 5 sets tested at 48 and 72 hours, and
knockdown was confirmed by real-time PCR in the Opticon 2 Real Time PCR Detector
System (Bio-Rad, Richmond, CA) (see Supplementary Figure 1, available on the Arthritis &
Rheumatism Web site at http://www.mrw.interscience.wiley.com/suppmat/0004-3591/
suppmat/). Seventy-two hours after transfection, cells were treated with 50 ng/ml TNFα in
serum-free medium for 24 hours, and cell death was assessed by staining with 10 μg/ml
Hoechst 33342 dye (Invitrogen) to detect chromatin condensation. Cell death was defined by
condensed and/or fragmented chromatin in the blue fluorescence–emitting nuclei. At least
200 cells from randomly selected fields were counted in each experiment. The significance
of the differences was estimated using analysis of variance followed by Student’s t-test. P
values less than 0.05 were considered significant.
RESULTS
Higher levels of GADD45β expression in early OA than in late OA
Based on our previous study (16), we hypothesized that GADD45β might be differentially
expressed in adult articular cartilage. Our initial screen used total RNA isolated from
cartilage samples from 3 patients with early OA and 3 patients with late OA. Microarray
analysis on Affymetrix GeneChip U133A identified 358 transcript variants (lower
confidence bound ≥1.2) that were highly expressed genes in cartilage from patients with
early OA. GADD45β was expressed 2.66-fold higher in early OA than in late OA (see
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Supplementary Table 1, available on the Arthritis & Rheumatism Web site at http://
www.mrw.interscience.wiley.com/suppmat/0004-3591/suppmat/).
Other genes up-regulated prominently in early OA encoded intracellular regulators of cell
proliferation (DDX11, CCNG1, HRASLS3, CDC25C, CHEK1, H2AFN, H2AFB, RAB26),
mitochondrial function (OXA1L, TOMM20, TIMM17A, CYP4B1, ACADL, COX7C,
CTAG1), cytoskeletal function (TMOD, ROCK1, VCL, HINT1, TLN4), ion transport
(SCNN1A, SCN2B, ACADL, CLDN4, NTT5), intracellular transport (LTF, GRM1, TFR2),
signal transduction (PIK3R1, MAP2K5, SWAP1, PDE9A, SSR4, PIK4CB, GRAF,
MAPK4, MSTIR, MAPK14), transcription (RREB1, ETV5, FOXG1A, SAP18, ZNF144,
ZNF254, ZNF277, ZNF363, SRY, SOX17), and protein translation and modification
(EIF4B, EIF4EBP2, RABBG-GTB, MAOA, ASB13). Genes associated with inflammation
(SAA2, C3, TNFRSF8, IL1R1), angiogenesis (FLT1, TIE, EPHB4, NRP2, BAI3), cell
adhesion (CDH7, GPC3, CELSR1, ITGA2, ITGA8, ITGB4, PCDH11), matrix degradation
(CSNK2A2, ADAM11, ADAM23, MMP10), and skeletal development (FGF4, FGF5,
FGF16, BMP7, MADHIP, FST, DVL2, PTCH, HOXA4, HOXB6, ALP1) were also up-
regulated in early OA (Supplementary Table 1).
Real-time PCR confirmed the differential expression of GADD45β mRNA in early and late,
or severe, OA cartilage samples analyzed by microarray (Figure 1A). Interestingly, severe
OA sample 3 was an autopsy specimen with histologic features consistent with a less severe
stage of OA than sample 1 or sample 2. We decided to include these data in this report, since
they illustrate the importance of uniform handling of material and because the Self
Organizing Map analysis also indicated sample 3 as an outlier. The Self Organizing Map
algorithm groups genes that have similar expression patterns within the same cluster.
As shown in Figure 1B, 30 distinct clusters were generated, of which 21 (c0–c11, c13–c17,
and c20–c23) contained genes that were primarily up-regulated in severe OA sample 1 and
severe OA sample 2, and 8 (c12, c18, c19, and c24–c28) contained genes that were up-
regulated in early OA sample 1, early OA sample 2, and early OA sample 3. The cluster c29
contained genes that were only slightly up-regulated in early OA. In some, but not all, of the
clusters, severe OA sample 3 was an outlier, particularly in clusters c0–c5. GADD45β
clustered in c25 with other intracellular mediators involved in transport, mitochondrial
function, and cell cycle regulation. The analysis of all 824 differentially expressed genes
indicated that many of the same genes were down-regulated in severe OA samples 1, 2, and
3, as shown for the top 54 differentially expressed genes in the heat map in Figure 1C. In
severe OA sample 3, however, most of the genes up-regulated in severe OA sample 1 and
severe OA sample 2 were down-regulated, as in the early OA samples.
Higher levels of GADD45β expression in normal cartilage than in cartilage from patients
with late-stage OA
To determine whether GADD45β expression in normal cartilage was up- or down-regulated
compared with OA cartilage, we analyzed a data set from Affymetrix GeneChip Whole
Genome U133 Plus 2.0, in which total RNA extracts from cartilage samples from 13 normal
donors and 12 patients with late-stage OA were compared. These data were subjected to
bioinformatics analysis by dChip in the BIDMC Genomics Center (http://
www.bidmcgenomics.org/), using lower confidence bound >1.2. As shown in the dChip
analysis in Figure 2, all 3 transcripts of GADD45β detected by the GeneChip were markedly
down-regulated in OA compared with normal cartilage samples. Consistent with a previous
report by Aigner et al (9), GADD45α was also decreased in OA relative to normal cartilage,
whereas GADD45γ was expressed at low levels with a lower confidence bound close to 1.2
(Figure 2A).
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Immunohistochemical analysis of GADD45β expression in adult human articular cartilage
Since analysis of global gene expression in extracts of whole cartilage samples does not take
into account the cellular distribution, we investigated the protein expression of GADD45β in
normal and OA cartilage at different stages to obtain some clues about its cellular
localization and function. Immunohistochemistry demonstrated nuclear localization of
GADD45β in all chondrocytes where it was expressed. GADD45β was present in
chondrocytes throughout the superficial and middle zones of normal cartilage (Figure 3A).
In early OA, some chondrocytes expressed GADD45β strongly, but with variable
distribution in the middle and superficial zones or in the deep zones. In late OA, few
chondrocytes stained for GADD45β (Figure 3A). GADD45β was strongly expressed in
chondrocyte clusters and also observed in cells throughout osteophytes (Figure 3B).
Up-regulation of COL2A1 and other extracellular matrix genes in cartilage from patients
with late-stage OA
Analysis using Affymetrix GeneChip U133A identified 466 transcripts (lower confidence
bound >1.2) that were highly expressed in late, or severe, OA (see Supplementary Table 2,
available on the Arthritis & Rheumatism Web site at http://
www.mrw.interscience.wiley.com/suppmat/0004-3591/suppmat/). Hierarchal clustering
analysis indicated that genes associated with extracellular matrix synthesis and anabolism
were up-regulated in late OA (Figure 1C). COL2A1 was among the most highly expressed
genes in clusters 0 and 1. The collagen genes, COL3A1, COL1A1, COL1A2, COL6A1,
COL6A3, COL5A1, COL5A2, and COL15A1, which were often represented more than
once in clusters 0, 1, 2, 3, 4, and 5, were all strongly up-regulated in cartilage from patients
with late OA compared with cartilage from patients with early OA (Supplementary Table 2).
COL9A3, COL11A1, COL9A2, and COL18A1 were found in clusters 6, 8, 20, and 22,
respectively. Genes involved in posttranslational modification of collagens (PCOLCE,
PLOD, P4HA2, LOXL1, and BMP1) and other matrix-associated genes such as those for
HXB, TNXB, OGN (mimecan), BGN, FN1, LUM, CSPG2, CHAD, SDC1, and SPARC
were also prominently represented.
Of interest were the other most highly expressed genes, including asporin (ASPN), matrilin
3 (MTN3), CILP, AQP1, S100A4, SGK, IGFBP7, IGFBP3, ANXA2, DKK3, WIF1,
CTKSF1B1, POSTN, and LTBP1, that play a role in cartilage development and
homeostasis. Other genes potentially involved in inflammation, angiogenesis, and stress
responses, including PTGES, VCAM1, TNFSF11, TNFSF10, TNFRSF11B
(osteoprotegerin), ANGPTL2, PLA2G4A, PRKCA, AXL, and GAS7, heat-shock proteins
22 (HSPB8), 27 (HSPB1), 47 (SERPINH1), 70 (HSPA1B), and 90 (HSPCA), and genes
involved in tissue catabolism (SERPINA5, SERPINE1, PRSS23, CTSK, and MMP13) were
also up-regulated. SDRG1, CRTAC1, FAP, MIA/CD-RAP, and NOTCH2 are of potential
interest as markers in cartilage from patients with late OA (Supplementary Table 2).
Negative regulation of COL2A1 mRNA and promoter activity by GADD45β
To further explore the reciprocal relationship between GADD45β and matrix gene
expression observed in our microarray analyses, we analyzed the influence of endogenous or
overexpressed GADD45β on COL2A1 mRNA levels and promoter activity in the human
chondrocyte C-28/I2 cells transduced with lentiviral siRNA-GFP (GFP-KD control) or
siRNA-GADD45β (GADD45β-KD) (16). The levels of COL2A1 mRNA, analyzed by
quantitative real-time RT-PCR, and COL2A1 promoter activity were increased by
GADD45β silencing (Figure 4A). Overexpression of GADD45β suppressed COL2A1
promoter activity in a dose-dependent manner. Cotransfection with GADD45β-FLAG
inhibited COL2A1 promoter activity compared with cotransfection with the control
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pcDNA3-FLAG vector (Figure 4B). These results suggest that GADD45β expression may
be associated with low collagen turnover in cartilage in physiologic conditions.
GADD45β is a survival factor in human articular chondrocytes
Since NF-κB is known to induce GADD45β during genotoxic and oxidative stress (28,35)
and to play an important role in TNFα-induced apoptosis in chondrocytes, we hypothesized
that the induction of GADD45β by NF-κB could represent a protective feedback mechanism
for cell survival, as shown in previous studies of other cell types (36,37). In addition, several
genes associated with apoptosis were differentially expressed in early and late OA, including
apoptosis antagonizing transcription factor (AATF), caspase 10 (CASP10), BCL2-
associated athanogene 3 (BAG3), apoptosis-related protein (APR), and apoptosis-related
cysteine proteinase (Supplementary Tables 1 and 2).
As shown in Figure 5, cotransfection of the NF-κB subunits p65 and p50 up-regulated
GADD45β promoter activity in C-28/I2 chondrocytes. Compared with the empty vector, p65
alone, but not p50, stimulated the activity of both promoter constructs. In cotransfections
with both p65 and p50, the level of −1,604 to +141 bp promoter activity was >2-fold greater
than in the presence of p65 or p50 alone. Of note, the activity of the shorter −496 to +141 bp
promoter in the presence of p65 alone was not significantly different from that in the
presence of both p65 and p50, consistent with the location of functional NF-κB sites
described previously (35). We then examined whether GADD45β could serve as a cell
survival signal, as reported for the NF-κB response in other cell types (28,36,37).
Knockdown of GADD45β expression after transfection of siRNA-GADD45β in cultured
human articular chondrocytes isolated from 5 patients increased cell death, measured by
Hoechst staining of condensed chromatin, in both the absence and the presence of TNFα
(Figure 6). These results indicated that GADD45β was a prosurvival signal in chondrocytes
and that endogenous levels were sufficient to protect against cell death.
DISCUSSION
Based on our recent findings that highlighted a new function of GADD45β in hypertrophic
chondrocytes during endochondral ossification (16), we investigated whether this stress
response factor might play a role in chondrocyte survival in adult articular cartilage. In our
initial screen of a small number of samples of cartilage with well-characterized pathology,
we found, surprisingly, a clear distinction between genes up-regulated in early and late OA,
using GADD45β and COL2A1, respectively, as “marker” genes. The down-regulation of
GADD45β in late (moderate to severe) OA was confirmed using a much larger data set from
the U133 Plus 2.0 array containing the whole human genome. Along with the Self
Organizing Map analysis showing that one of the late OA samples was an outlier, these data
demonstrated the value of comparisons among individual samples. The consistency and
statistical significance of differences in global gene expression were surprising because of
the heterogeneity in proliferative and synthetic activities that we would expect at any given
time among cells within individual human cartilage samples. Immunohistochemical analysis
of individual cartilage samples also supported the assumptions derived from the microarray
data. The expression of GADD45β in all chondrocytes throughout normal articular cartilage,
in addition to its localization in early OA cartilage at sites peripheral to the lesion and in
chondrocyte clusters and osteophytes, along with our finding that endogenous levels protect
against cell death in articular chondrocyte cultures, suggests a role of GADD45β as a
survival factor in chondrocytes in both health and disease.
Consistent with the low levels of COL2A1 in normal and early OA cartilage, GADD45β
down-regulated COL2A1 promoter activity and mRNA levels in chondrocyte cultures. In
the mouse embryo, GADD45β is required for expression of the type X collagen gene during
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chondrocyte hypertrophy (16), and our present results suggest that it may also be associated
with decreased COL2A1 transcription during terminal differentiation. The increased
expression of the vascular endothelial growth factor receptors, FLT1 and NRP2, which
mediate angiogenesis during endochondral ossification, and other genes associated with
skeletal development in cartilage samples from patients with early OA, supports this
concept. Thus, GADD45β may be an important signal that serves as the molecular link
common to pathways of cartilage remodeling in endochondral ossification and in OA.
Previous studies have shown that gene expression and synthesis of type II collagen are up-
regulated in OA cartilage even though catabolic activity leads finally to the destruction of
the matrix (38–40). Thus, the endogenous levels of GADD45β in normal cartilage may
reflect the low matrix synthetic activity in quiescent chondrocytes under low turnover
conditions. The up-regulation of other matrix genes, including those for types I, III, and V
collagens and MTN3, in late OA may reflect, however, an aberrant attempt at repair. Despite
the high levels of COL2A1 in late OA cartilage, SOX9, the master switch for the COL2A1
phenotype, was not differentially expressed, consistent with findings that SOX9 mRNA is
decreased near the lesions in OA cartilage (41), and that SOX9 and COL2A1 expression do
not colocalize in adult articular cartilage (42). The differential up-regulation of transcription
factors, such as MAF, SOX4, PMX1, FosB, RUNX1, DLX4, ELF2, NFAT5, and zinc-finger
protein 42 (ZNF42), ZNF131, and ZNF137, suggests alternative mechanisms for regulating
the other differentially expressed genes in cartilage in patients with late OA, whereas
distinct transcription factors, including RREB1, ETV5, FOXG1A, SAP18, ZNF144,
ZNF254, ZNF277, ZNF363, SRY, and SOX17, were up-regulated in early OA.
Although this is the first report of differential expression of GADD45β in normal and OA
human cartilage, our results confirmed previous findings of microarray studies of other
genes, particularly matrix genes (10,43). Genome-wide scans in OA patients have identified
polymorphisms in MTN3 (44), ASPN, which inhibits cartilage anabolism by binding to
transforming growth factor β (45), and other genes (46) that were also up-regulated in late
OA in our microarray analysis. Of interest were genes with prominent roles in anabolism,
including CILP, AQP1, S100A4, IGFBP7, and ANXA2. The increased expression of the
Wnt-associated genes, including DKK3, WIF1, and SFRP4, as well as CKTSF1B1, POSTN,
LTBP1, TGFB1I4, FGF2, FGF18, Gli3, DLX4, and ACVR1B, suggests additional
mechanisms due to modified biologic activities in the calcified cartilage and subchondral
bone (47–49).
Other genes involved in regulating skeletal development were differentially up-regulated in
early OA. We reported previously that RUNX2 is involved in the induction of GADD45β,
resulting in induction of MMP13 in hypertrophic chondrocytes (16). RUNX2 (data not
shown) and MMP13 were expressed in early OA, although at higher levels in late OA,
suggesting that RUNX2 is not the only requirement for GADD45β expression in adult
articular cartilage. The presence of GADD45β in osteophytes, outgrowths from the
periosteum that undergo endochondral ossification, also suggests its involvement in
unsuccessful repair.
Regarding OA pathogenesis, few of the obvious candidates were identified. Genes
associated with inflammation, angiogenesis, cell adhesion, and matrix degradation were up-
regulated in early OA. Many of these genes were differentially expressed with relatively low
fold change and lower confidence bound, reflected in the cluster analysis, suggesting that
they may be expressed at early stages of OA and throughout the progression of the disease.
For example, MMP10 has been implicated as a collagenase activator during cartilage
degradation in arthritis (50). In late-stage OA, TNF superfamily members and heat-shock
proteins may represent responses to stress and inflammation. Although serine proteinase
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inhibitors, SERPINA5 and SERPINE1, are expressed along with few proteinases other than
PRSS23 (serine protease 23), cathepsin K (a cysteine proteinase), and MMP13, the level of
catabolic activity in late-stage OA cannot be predicted by these results. Other candidates for
further study for which novel roles have been identified in cartilage include SDRG1 (51),
CRTAC1 (52), FAP (53), MIA/CD-RAP (54), and NOTCH2 (55).
In adult articular cartilage, chondrocytes are quiescent, and cell survival and anabolic
activity are essential for maintenance of this avascular tissue. Thus, chondrocyte apoptosis
may have significant consequences in the pathogenesis of OA, although its importance in
the slowly progressing disease in humans is controversial (12). Studies showing increased
chondrocyte death in response to injurious compression support the idea of an association
between apoptosis and increased stress (56). The presence of GADD45β in the nuclei of
nonmitotic chondrocytes and the differential expression of several apoptosis-related genes in
OA cartilage are consistent with its described role in other tissues as an antiapoptotic
molecule. GADD45β is associated with G2/M cell cycle arrest (57), and its interaction with
MTK1/MEKK4 promotes activation of JNK, as well as p38 MAPK (58). However,
GADD45β interaction with MKK7, resulting in inhibition of TNFα-induced JNK activity by
engaging the ATP-binding site, is responsible for the antiapoptotic activity of NF-κB
(36,37,59). Thus, inadequate levels of GADD45β and sustained activation of JNK by
mediators of inflammation may explain the proapoptotic response to NF-κB in some cell
types (60). Our finding that endogenous levels of GADD45β protect against TNFα-induced
cell death suggests a role for this survival factor as a feedback regulatory molecule during
acute cell stress. Interestingly, the tumor suppressor CYLD, which is induced by TNFα and
negatively regulates NF-κB signaling (61) and adlican, which is involved in colon cancer
progression (62), were both up-regulated in cartilage from patients with late-stage OA.
Overall, our results indicate that GADD45β is a key factor contributing to physiologic
cartilage homeostasis and to the imbalance in matrix remodeling in OA cartilage, as well as
to chondrocyte survival after cell cycle arrest.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Comparison of gene expression patterns in cartilage samples from patients with early
osteoarthritis (OA) and patients with late-stage OA. A, Growth arrest and DNA damage–
inducible protein β (GADD45β) expression in cartilage samples from patients with early OA
and patients with late-stage OA. RNA extracts from cartilage samples obtained from 3
patients with early OA (eOA1–eOA3) and 3 patients with late, or severe, OA (sOA1–sOA3)
were analyzed by quantitative real-time polymerase chain reaction. Each sample was
analyzed in triplicate. Bars show the mean and SD ratio of GADD45β to GAPDH. B, Self
Organizing Map analysis of gene expression in cartilage samples from patients with early or
severe OA. The algorithm generated 30 distinct clusters (c0–c29), each representing genes
with a similar expression pattern. Each square in the grid corresponds to 1 cluster. The
number in the top left of each square is the cluster ID. The yellow box around c0 marks the
first cluster obtained in the analysis. The number in the top middle of each square is the
number of genes in the cluster. Blue dots represent the average expression patterns of the
genes in each cluster in (from left to right) severe OA sample 1, severe OA sample 2, severe
OA sample 3, early OA sample 1, early OA sample 2, and early OA sample 3. Red lines
represent the variation from the average expression pattern. Note that severe OA sample 3 is
an outlier with respect to genes that are up-regulated in severe OA. C, Hierarchical
clustering analysis of the microarray data from cartilage samples obtained from 3 patients
with early OA and 3 patients with late OA, analyzed using Affymetrix GeneChip U133A.
Up-regulated genes are shown in red; down-regulated genes are shown in green. Black
indicates no change. GADD45β gene expression was up-regulated in early OA, along with
genes involved in cell cycle regulation, such as DDX11, HRASLS3, and CCNG1, and in
mitochondrial function, such as OXA1L and TOMM20, as well as other genes involved in
intracellular functions. The genes encoding types I, II, III, and V collagen were all up-
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regulated in late OA compared with early OA, as were ASPN, MTN3, and the Wnt-
associated genes, WIF1 and DKK3.
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Figure 2.
Microarray analysis of normal (N) and OA cartilage. RNA extracts from cartilage samples
from 13 normal donors and 12 patients with late-stage OA were analyzed using Affymetrix
GeneChip U133 Plus 2.0, and the data were subjected to bioinformatic analysis with dChip
software, using a lower confidence bound (LCB) of >1.2. A, Fold change (FC) in expression
of GADD45β, GADD45α, and GADD45γ transcripts in normal compared with OA
cartilage. Values are the mean ± SEM. The probe ID is the Affymetrix identifier for separate
probes on the microarray. B–D, Individual values in each normal and OA cartilage sample
for each of the 3 GADD45β probes. See Figure 1 for other definitions.
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Figure 3.
Immunohistochemical analysis of GADD45β expression in representative specimens of
human adult articular cartilage, including those used in the microarray analyses. A, Cartilage
sections from a normal donor (Mankin grade 0) (a–c), a patient with early OA (Mankin
grade 4) (d–f), and a patient with late-stage OA (Mankin grade 8) (g–i) were stained with
toluidine blue or subjected to immunohistochemistry using anti-GADD45β or normal goat
IgG (negative control). Arrows in b and e show single cells with nuclear staining (original
magnification × 40). B, Sections with chondrocyte clusters in the middle zone from a patient
with early OA (Mankin grade 4) (a–c) and an osteophyte from a patient with late OA
(Mankin grade 8) (d–f) were stained with toluidine blue or immunostained with anti-
GADD45β or normal goat IgG. Boxed areas in a and d are shown at higher magnification in
b and e. See Figure 1 for other definitions.
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Figure 4.
Increased COL2A1 mRNA and promoter activity after small interfering RNA (siRNA)
blockade of endogenous growth arrest and DNA damage–inducible protein β (GADD45β).
A, Total RNA was extracted from cultures of C-28/I2 cells transduced with lentiviral
siRNA–green fluorescent protein (GFP) (GFP–knockdown [KD]) or siRNA-GADD45β
(GADD45β-KD) (left). Quantitative real-time reverse transcriptase–polymerase chain
reaction analysis was performed to determine the levels of COL2A1 mRNA normalized to
GAPDH mRNA. GFP-KD and GADD45β-KD C-28/I2 cells were transfected with pGL2-B/
4.0, and COL2A1 promoter–driven luciferase activity was measured (right). B, C-28/I2 cells
were cotransfected with pGL2-B/4.0 (COL2A1, spanning −577 to +3,428 bp) and pcDNA3-
FLAG (control) or increasing amounts of GADD45β-FLAG, as indicated. Bars show the
mean and SD of triplicate wells.
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Figure 5.
Induction of growth arrest and DNA damage–inducible protein β (GADD45β) by NF-κB in
chondrocytes. C-28/I2 cells were cotransfected with pGL2-GADD45β promoter constructs
−1,604 to +141 bp (A) and −496 to +141 bp (B), and the empty vector, pCI, or expression
vector encoding the NF-κB subunit p65 alone, the NF-κB subunit p50 alone, or both p65
and p50. Bars show the mean and SD.
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Figure 6.
Growth arrest and DNA damage–inducible protein β (GADD45β) is a cell survival factor in
human articular chondrocytes. Primary cultures were passaged at 2.5 × 104 cells/cm2, grown
to confluence, transfected with small interfering RNA (siRNA)–GFP (siGFP) or siRNA-
GADD45β oligos, and treated 72 hours later with tumor necrosis factor α (TNFα) for 24
hours. A, Cell death was evaluated by staining with Hoechst 33342 and counting the number
of nuclei with brightly stained condensed chromatin. Bars show the mean ± SD percentage
of cells showing nuclear condensation and fragmentation relative to the total number of cells
counted (≥200 cells per data point). Results are from ≥4 independent experiments, each
performed in triplicate. B, Representative photomicrographs of Hoechst-stained cells from 1
set of cultures isolated from a single patient are shown.
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